Searched for
HOSPIRA
Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...- Dr Reddy's loses patent case with Eli Lilly over AlimtaThe U.S. District Court for the Southern District of Indiana ruled in favor of Lilly, a release from the US drug maker said.
- Pfizer plans to bring more global drugs to IndiaAlthough the company sells most of its top 20 global products in India, it is looking to bring in a couple of drugs, the patents of which h...
- Pfizer shares gain over 3% as parent plans to buy HospiraShares of Pfizer rose by over 3 per cent as pharmaceuticals giant Pfizer Inc will acquire Hospira Inc, a leading provider of injectable dru...
- Pfizer rallies over 6% on acquisition plans; scales above Rs 2000As per the report, Pfizer offered $90 per share in cash, a 39 percent premium to Hospira's closing stock price on Wednesday
- Pfizer buying Hospira for about $15 billionThe deal is expected to add 10-12 cents per share to Pfizer's earnings in the first full-year after the deal closes.
- Pfizer buying Hospira for about $15.23 billionPfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business.
- Wockhardt, Cadila and Hospira voluntarily recall drugs in USDrug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in US, according to the US Food and Dru...
- Aurobindo Pharma lands in patent litigation cases in USAIndian firm Aurobindo Pharma has been dragged to court by three multi-national drug makers on allegations of patent infringement.
- Orchid Chemicals gets CCI nod for Hospira dealCompetition Commission of India today said it has approved a proposed sale by Orchid Chemicals and Pharmaceuticals Ltd (OCPL) of its certai...
- Orchid Chemicals's facility sale more of a desperate attempt to improve the balance sheetOrchid Chemicals sale of its penicillin and penem API facility to US-based Hospira is more of a desperate attempt to cut down debt rather t...
- Orchid Chemicals up over 5%Orchid Chem gained after it plans to sell various assets including active pharmaceutical ingredients biz and one R&D facility to the US-bas...
- US based Hospira to buy Orchid's API manufacturing, R&D units in $200 million dealOrchid Chemicals today said it will sell various assets including active pharmaceutical ingredients (API) business and a R&D facility to Ho...
- Hospira acquires Orchid Chemicals for $400 mnIt is a win-win situation for both the US-based pharma company Hospira and Chennai-based Orchid Chemicals and Pharmaceuticals.
- 'A win-win deal for both firms'Though mkt gave big thumbs-down to the blockbuster deal between Orchid Chemicals and Hospira, Orchid founder and MD K Raghavendra Rao told ...
- Orchid Chemicals to retire $260 mn in short-term debtsOrchid Chemicals and Pharmaceuticals, which sold off its pharma business to Hospira for a consideration of $400 mn, plans to use the funds ...
- Orchid Chemicals deal to repair balance sheet, boost growthHospira is set to acquire Orchid Chemical’s generic injectable pharma business for $400 million.
- Most money from the deal will be sued to repay debt: Orchid ChemicalsOrchid Chemicals has sold its Injectable Business to Hospira. K Raghavendra Rao, MD, Orchid Chemicals talks to ET NOW about the deal.
- US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mnOrchid Chemicals & Pharmaceuticals to sell its injectables business to the US-based Hospira for around $400 million.
- Hospira-Mayne deal likely to alter pharma equations hereOne of the biggest trans-continent deals in the generic pharma sector is likely open the floodgates of opportunities for the Indian pharma ...
Load More
